Cargando…
High-dose thalidomide increases the risk of peripheral neuropathy in the treatment of ankylosing spondylitis
Thalidomide is an effective drug for the treatment of ankylosing spondylitis but might induce peripheral neuropathy. This major adverse reaction has attracted much concern. The current study aimed to observe the incidence of thalidomide-induced peripheral neuropathy among ankylosing spondylitis pati...
Autores principales: | Xue, Hong-xia, Fu, Wen-yi, Cui, Hua-dong, Yang, Li-li, Zhang, Ning, Zhao, Li-juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468777/ https://www.ncbi.nlm.nih.gov/pubmed/26109960 http://dx.doi.org/10.4103/1673-5374.156988 |
Ejemplares similares
-
The absolute counts of peripheral T lymphocyte subsets in patient with ankylosing spondylitis and the effect of low-dose interleukin-2
por: An, Haizhuan, et al.
Publicado: (2019) -
Increased Left Putamen Volume Correlates With Pain in Ankylosing Spondylitis Patients
por: Hua, Kelei, et al.
Publicado: (2020) -
Circular RNAs in peripheral blood mononuclear cells from ankylosing spondylitis
por: Tang, Yi-Ping, et al.
Publicado: (2021) -
Ankylosing spondylitis
Publicado: (1980) -
Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010)